Get complete Patent Opposition Report for Glaxosmithkline Uk

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore patent oppositions filed by Glaxosmithkline Uk against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP2289531Medicaments For Increasing Endogenous Erythropoietine (Epo)FIBROGENFeb 19, 2020
EP2322153Use Of Hif Alpha Stabilizers For Enhancing ErythropoiesisFIBROGENJun 26, 2019